QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)
QQQ   425.61 (-0.40%)
AAPL   182.32 (+0.42%)
MSFT   402.18 (-0.15%)
META   468.03 (-0.68%)
GOOGL   142.55 (+1.01%)
AMZN   168.59 (+0.90%)
TSLA   194.77 (+0.52%)
NVDA   674.72 (-2.85%)
NIO   5.97 (+0.17%)
AMD   164.29 (-0.84%)
BABA   75.58 (+3.34%)
T   17.01 (+0.59%)
F   12.15 (-0.82%)
MU   81.49 (+0.97%)
CGC   3.44 (-2.82%)
GE   149.08 (+0.31%)
DIS   107.68 (-1.61%)
AMC   4.57 (-1.93%)
PFE   27.67 (+0.29%)
PYPL   57.48 (-1.96%)
XOM   104.86 (+2.05%)

Intercept Pharmaceuticals (ICPT) Short Interest Ratio & Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.

Intercept Pharmaceuticals Short Interest Data

Current Short Volume
10,190,000 shares
Previous Short Volume
9,430,000 shares
Change Vs. Previous Month
+8.06%
Dollar Volume Sold Short
$185.46 million
Short Interest Ratio / Days to Cover
5.3
Last Record Date
October 15, 2023
Outstanding Shares
41,830,000 shares
Float Size
33,790,000 shares
Short Percent of Float
30.16%
Today's Trading Volume
0 shares
Average Trading Volume
1,362,029 shares
Today's Volume Vs. Average
0%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Intercept Pharmaceuticals ?

Sign up to receive the latest short interest report for Intercept Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ICPT Short Interest Over Time

ICPT Days to Cover Over Time

ICPT Percentage of Float Shorted Over Time


Intercept Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202310,190,000 shares $185.46 million +8.1%30.2%5.3 $18.20
9/30/20239,430,000 shares $174.83 million -23.6%27.9%5.5 $18.54
9/15/202312,340,000 shares $141.29 million +18.7%36.5%8.5 $11.45
8/31/202310,400,000 shares $112.63 million +9.2%29.0%10.5 $10.83
8/15/20239,520,000 shares $97.68 million +11.6%26.6%8.7 $10.26
7/31/20238,530,000 shares $92.12 million +14.0%24.1%6.3 $10.80
7/15/20237,480,000 shares $84.45 million +4.0%21.2%5.5 $11.29
6/30/20237,190,000 shares $79.52 million +12.5%20.4%5.2 $11.06
6/15/20236,390,000 shares $75.53 million +23.6%18.1%5 $11.82
5/31/20235,170,000 shares $54.49 million +61.6%14.7%4.4 $10.54
5/15/20233,200,000 shares $52.64 million No Change9.1%3 $16.45
10/31/20224,170,000 shares $57.84 million +3.7%N/A4.1 $13.87
10/15/20224,020,000 shares $54.47 million -22.1%N/A3.8 $13.55
9/30/20225,160,000 shares $71.98 million +4.0%21.7%4.8 $13.95
9/15/20224,960,000 shares $87.15 million -9.7%20.9%5.2 $17.57
8/31/20225,490,000 shares $95.36 million -52.5%23.2%6.1 $17.37
8/15/202211,560,000 shares $210.28 million +8.4%48.8%12.9 $18.19
7/31/202210,660,000 shares $136.02 million +3.1%45.1%12.6 $12.76
7/15/202210,340,000 shares $149.93 million +15.9%43.8%10.5 $14.50
6/30/20228,920,000 shares $123.19 million -8.6%37.8%9.1 $13.81
6/15/20229,760,000 shares $115.66 million +9.5%41.3%9.9 $11.85
5/31/20228,910,000 shares $161.27 million +2.0%37.7%8.8 $18.10
5/15/20228,740,000 shares $156.27 million +9.4%36.9%8.5 $17.88
4/30/20227,990,000 shares $125.52 million -2.9%33.8%7.9 $15.71
4/15/20228,230,000 shares $135.55 million -0.1%34.8%10.3 $16.47
3/31/20228,240,000 shares $134.06 million -3.1%N/A9.9 $16.27
3/15/20228,500,000 shares $121.21 million -0.7%36.0%10.6 $14.26
2/28/20228,560,000 shares $122.07 million +2.0%36.2%10.2 $14.26
2/15/20228,390,000 shares $133.65 million +0.2%35.7%10.1 $15.93
1/31/20228,370,000 shares $137.18 million -0.1%35.6%10 $16.39
1/15/20228,380,000 shares $148.83 million -0.4%N/A9.2 $17.76
12/31/20218,410,000 shares $137.00 million -2.2%35.7%9.6 $16.29
12/15/20218,600,000 shares $129.77 million +3.1%36.5%10.3 $15.09
11/30/20218,340,000 shares $143.53 million -0.4%34.4%10.5 $17.21
11/15/20218,370,000 shares $147.90 million +11.2%34.5%10.3 $17.67
10/29/20217,530,000 shares $126.96 million -2.7%31.1%7.3 $16.86
10/15/20217,740,000 shares $130.19 million -2.5%28.4%8.5 $16.82
9/30/20217,940,000 shares $117.91 million -6.6%29.2%8.9 $14.85
9/15/20218,500,000 shares $128.18 million +10.4%31.2%9.7 $15.08
8/31/20217,700,000 shares $114.81 million -9.4%28.3%9.3 $14.91













ICPT Short Interest - Frequently Asked Questions

What is Intercept Pharmaceuticals' current short interest?

Short interest is the volume of Intercept Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 10,190,000 shares of ICPT short. 30.16% of Intercept Pharmaceuticals' shares are currently sold short. Learn More on Intercept Pharmaceuticals' current short interest.

What is a good short interest ratio for Intercept Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ICPT shares currently have a short interest ratio of 5.0. Learn More on Intercept Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Intercept Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Intercept Pharmaceuticals: GTS Securities LLC, Mint Tower Capital Management B.V., Citadel Advisors LLC, Balyasny Asset Management L.P., Harvest Management LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, Wolverine Asset Management LLC, and Cutler Group LLC CA. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Intercept Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 30.16% of Intercept Pharmaceuticals' floating shares are currently sold short.

Is Intercept Pharmaceuticals' short interest increasing or decreasing?

Intercept Pharmaceuticals saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 10,190,000 shares, an increase of 8.1% from the previous total of 9,430,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Intercept Pharmaceuticals' float size?

Intercept Pharmaceuticals currently has issued a total of 41,830,000 shares. Some of Intercept Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Intercept Pharmaceuticals currently has a public float of 33,790,000 shares.

How does Intercept Pharmaceuticals' short interest compare to its competitors?

30.16% of Intercept Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Intercept Pharmaceuticals: Avidity Biosciences, Inc. (10.31%), Novavax, Inc. (43.85%), OmniAb, Inc. (5.40%), AnaptysBio, Inc. (22.20%), Replimune Group, Inc. (17.18%), Anavex Life Sciences Corp. (24.52%), Mersana Therapeutics, Inc. (5.51%), ESSA Pharma Inc. (7.06%), Orchard Therapeutics plc (0.14%), Arcus Biosciences, Inc. (22.34%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.82 billion), T-Mobile US, Inc. ($3.69 billion), Occidental Petroleum Co. ($2.90 billion), TC Energy Co. ($2.74 billion), Tractor Supply ($2.28 billion), Rivian Automotive, Inc. ($1.92 billion), Moderna, Inc. ($1.77 billion), Celsius Holdings, Inc. ($1.72 billion), Coinbase Global, Inc. ($1.66 billion), and Royal Caribbean Cruises Ltd. ($1.65 billion). View all of the most shorted stocks.

What does it mean to sell short Intercept Pharmaceuticals stock?

Short selling ICPT is an investing strategy that aims to generate trading profit from Intercept Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Intercept Pharmaceuticals?

A short squeeze for Intercept Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ICPT, which in turn drives the price of the stock up even further.

How often is Intercept Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ICPT, twice per month. The most recent reporting period available is October, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ICPT) was last updated on 2/21/2024 by MarketBeat.com Staff